214 related articles for article (PubMed ID: 1560438)
1. Low molecular weight proteins as carriers for renal drug targeting. Preparation of drug-protein conjugates and drug-spacer derivatives and their catabolism in renal cortex homogenates and lysosomal lysates.
Franssen EJ; Koiter J; Kuipers CA; Bruins AP; Moolenaar F; de Zeeuw D; Kruizinga WH; Kellogg RM; Meijer DK
J Med Chem; 1992 Apr; 35(7):1246-59. PubMed ID: 1560438
[TBL] [Abstract][Full Text] [Related]
2. Low molecular weight proteins as carriers for renal drug targeting: naproxen coupled to lysozyme via the spacer L-lactic acid.
Franssen EJ; Moolenaar F; de Zeeuw D; Meijer DK
Pharm Res; 1993 Jul; 10(7):963-9. PubMed ID: 8378258
[TBL] [Abstract][Full Text] [Related]
3. Low molecular weight proteins as carriers for renal drug targeting: naproxen-lysozyme.
Franssen EJ; van Amsterdam RG; Visser J; Moolenaar F; de Zeeuw D; Meijer DK
Pharm Res; 1991 Oct; 8(10):1223-30. PubMed ID: 1796038
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and in vitro testing of methotrexate carrier conjugates linked via oligopeptide spacers.
Fitzpatrick JJ; Garnett MC
Anticancer Drug Des; 1995 Jan; 10(1):1-9. PubMed ID: 7695810
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of low-molecular weight protein (LMWP) lysozyme-curcumin conjugates for kidney drug targeting.
Wang Y; Sun Y; Wang H; Liu P; Peng W; Duan Y
J Biomater Sci Polym Ed; 2013; 24(11):1360-7. PubMed ID: 23796036
[TBL] [Abstract][Full Text] [Related]
6. A covalent linkage between daunorubicin and proteins that is stable in serum and reversible by lysosomal hydrolases, as required for a lysosomotropic drug-carrier conjugate: in vitro and in vivo studies.
Trouet A; Masquelier M; Baurain R; Deprez-De Campeneere D
Proc Natl Acad Sci U S A; 1982 Jan; 79(2):626-9. PubMed ID: 6952214
[TBL] [Abstract][Full Text] [Related]
7. Drug-targeting to the kidney: renal delivery and degradation of a naproxen-lysozyme conjugate in vivo.
Haas M; Kluppel AC; Wartna ES; Moolenaar F; Meijer DK; de Jong PE; de Zeeuw D
Kidney Int; 1997 Dec; 52(6):1693-9. PubMed ID: 9407519
[TBL] [Abstract][Full Text] [Related]
8. Polymer conjugates of doxorubicin bound through an amide and hydrazone bond: Impact of the carrier structure onto synergistic action in the treatment of solid tumours.
Etrych T; Subr V; Laga R; Ríhová B; Ulbrich K
Eur J Pharm Sci; 2014 Jul; 58():1-12. PubMed ID: 24632485
[TBL] [Abstract][Full Text] [Related]
9. Effect of low molecular weight proteins and dextran on renal cathepsin B and L activity.
Olbricht CJ; Gutjahr E; Cannon JK; Irmler H; Tisher CC
Kidney Int; 1990 Mar; 37(3):918-26. PubMed ID: 1690311
[TBL] [Abstract][Full Text] [Related]
10. Lysosomal degradability of poly(alpha-amino acids).
Chiu HC; Kopecková P; Deshmane SS; Kopecek J
J Biomed Mater Res; 1997 Mar; 34(3):381-92. PubMed ID: 9086408
[TBL] [Abstract][Full Text] [Related]
11. Specific drug delivery to the kidney.
Haas M; Moolenaar F; Meijer DK; de Zeeuw D
Cardiovasc Drugs Ther; 2002 Dec; 16(6):489-96. PubMed ID: 12766381
[TBL] [Abstract][Full Text] [Related]
12. Biodegradable microspheres. 17. Lysosomal degradation of primaquine-peptide spacer arms.
Borissova R; Stjärnkvist P; Karlsson MO; Sjöholm I
J Pharm Sci; 1995 Feb; 84(2):256-62. PubMed ID: 7738812
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterization and stability of dendrimer prodrugs.
Najlah M; Freeman S; Attwood D; D'Emanuele A
Int J Pharm; 2006 Feb; 308(1-2):175-82. PubMed ID: 16384673
[TBL] [Abstract][Full Text] [Related]
14. 5-Fluorouracil acetic acid/beta-cyclodextrin conjugates: drug release behavior in enzymatic and rat cecal media.
Udo K; Hokonohara K; Motoyama K; Arima H; Hirayama F; Uekama K
Int J Pharm; 2010 Mar; 388(1-2):95-100. PubMed ID: 20036722
[TBL] [Abstract][Full Text] [Related]
15. Systematic research of peptide spacers controlling drug release from macromolecular prodrug system, carboxymethyldextran polyalcohol-peptide-drug conjugates.
Shiose Y; Kuga H; Ohki H; Ikeda M; Yamashita F; Hashida M
Bioconjug Chem; 2009 Jan; 20(1):60-70. PubMed ID: 19090781
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic carboxypeptidase hydrolysis of bile acid-amino conjugates: selective resistance of glycine and taurine amidates.
Huijghebaert SM; Hofmann AF
Gastroenterology; 1986 Feb; 90(2):306-15. PubMed ID: 2867000
[TBL] [Abstract][Full Text] [Related]
17. Biodegradable star HPMA polymer conjugates of doxorubicin for passive tumor targeting.
Etrych T; Strohalm J; Chytil P; Černoch P; Starovoytova L; Pechar M; Ulbrich K
Eur J Pharm Sci; 2011 Apr; 42(5):527-39. PubMed ID: 21392579
[TBL] [Abstract][Full Text] [Related]
18. ATP activation of protein degradation by extracts of crude and purified lysosomal preparations.
Pillai S; Zull JE
Biochim Biophys Acta; 1985 Nov; 843(1-2):92-100. PubMed ID: 3851674
[TBL] [Abstract][Full Text] [Related]
19. Fine tuning of the pH-dependent drug release rate from polyHPMA-ellipticinium conjugates.
Sedláček O; Studenovský M; Větvička D; Ulbrich K; Hrubý M
Bioorg Med Chem; 2013 Sep; 21(18):5669-72. PubMed ID: 23941688
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, physiochemical characterization, and in vitro antitumor activity of the amide and pH cleavable hydrazone conjugates of γ-tocotrienol isomer of vitamin E with methoxy-poly(ethylene) glycol.
Abu-Fayyad A; Nazzal S
Int J Pharm; 2017 Aug; 529(1-2):75-86. PubMed ID: 28627454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
